Improving chemotherapy delivery
ExpiredMSU research team creates new way to monitor chemotherapy concentrations for treatments
Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients’ treatments within the crucial therapeutic window.
With new advances in medicine happening daily, there’s still plenty of guesswork when it comes to administering chemotherapy to cancer patients. Too high a dose can result in killing healthy tissue and cells, triggering more side effects or even death; too low a dose may stun, rather than kill, cancer cells, allowing them to come back, in many cases, much stronger and deadlier.
Tiny bubbles in our body could fight cancer better than chemo
ExpiredNano-sized bubbles in our body could become mini treatment transporters, carrying a combination of therapeutic drugs and genes that target cancer cells and kill them
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It’s your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
These bubbly extracellular vesicles could become mini treatment transporters, carrying a combination of therapeutic drugs and genes that target cancer cells and kill them, according to new research from Michigan State University and Stanford University.
VanCamp Incubator + Research Labs Launch
The University Corporate Research Park has launched its newest property
The University Corporate Research Park, or UCRP, a wholly owned subsidiary of the MSU Foundation, has launched its newest property, the VanCamp Incubator + Research Labs.
The VanCamp Incubator is a 22,000-square-foot multi-tenant facility welcoming emerging companies and researcher groups across the Greater Lansing region and beyond. A ribbon cutting ceremony marking the building’s grand opening was held Thursday, Sept. 12. The incubator is now open to companies from the region as well as those coming directly out of the MSU ecosystem.
Gene mutation combo linked to common cancer in women
Michigan State University researchers, in collaboration with Van Andel Institute, have identified a combination of two gene mutations that is linked to endometrial cancer.
“More than 63,000 women are likely to be diagnosed with endometrial cancer this year, making it the most commonly identified type of gynecologic cancer,” said Ronald Chandler, phD, an assistant professor of obstetrics, gynecology and reproductive biology in the College of Human Medicine, who led the study.